Etcembly
1 known investors
Etcembly builds EMLy Co-pilot, an AI platform with a conversational interface that unifies biologics design workflows—including structural modeling, variant generation, and molecule optimization—into a single tool. It serves biotechs and R&D organizations working on therapeutic candidates such as antibodies (mAbs) and TCRs.
Investors · 1
Frequently asked questions
- What does Etcembly do?
- Etcembly builds EMLy Co-pilot, an AI platform with a conversational interface that unifies biologics design workflows—including structural modeling, variant generation, and molecule optimization—into a single tool. It serves biotechs and R&D organizations working on therapeutic candidates such as antibodies (mAbs) and TCRs.
- Who are Etcembly's investors?
- Etcembly's investors include Oxford Technology Management.